ODDB.org: Open Drug Database

Swissmedic Registration	48557	Date of registration	29.12.1986
Company name	IBSA Institut Biochimique SA	Revision date	31.10.2005
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	07.10.60.	Revocation Date
Index Therapeuticus (Swissmedic)	07.10.60.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Condrosulf 400	granulato in bustine	granulato in bustine (Chondroitine Sodium Sulfate 400 mg)	M01AX25	CI
02	Condrosulf 800	granulato in bustine	granulato in bustine (Chondroitine Sodium Sulfate 800 mg)	M01AX25	CI

2025	©ywesee GmbH